Companies Disrupting the Healthcare Industry: THRM.V/TBRIF, HMNU, HALB, PBIO, IPA, BLFE, RSHN

August 19, 2022

Any industry that depends a lot on innovation is prone to be disrupted and it is often seen that those disruptive companies go on to create significant wealth for their investors. However, at the same time, it is necessary for investors to do their research diligently and then come up with stocks that may be worth following. This article is going to give you a glimpse into four companies that…

Read More >>

ImmunoPrecise (NASDAQ:IPA) Reports $19.4 million Record Revenues of for Full Fiscal Year 2022 Dually Listed Co’s THRM.V/TBRIF, RFR.C/RFHRF, SFET/SFET.TA, AMY.V/AMYZF, GEMS.C / TLOOF

July 29, 2022

IPA/IMMUNOPRECISE ANTIBODIES LTD. – (NASDAQ: IPA) (TSXV: IPA), an advanced biotherapeutic research and technology company, today announced financial results for the full fiscal year 2022 ended April 30, 2022. The Company achieved record revenues of $19.4 million, up 8.1% from $17.9 million in the fiscal year 2021 The Company achieved record revenues of $5.2 million for the three months ended April 30, 2022, an increase of 7.4% over the same…

Read More >>